Jerauld S. Skotnicki

2.4k total citations
51 papers, 1.7k citations indexed

About

Jerauld S. Skotnicki is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Jerauld S. Skotnicki has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Organic Chemistry and 17 papers in Cancer Research. Recurrent topics in Jerauld S. Skotnicki's work include Protease and Inhibitor Mechanisms (16 papers), Peptidase Inhibition and Analysis (13 papers) and Signaling Pathways in Disease (9 papers). Jerauld S. Skotnicki is often cited by papers focused on Protease and Inhibitor Mechanisms (16 papers), Peptidase Inhibition and Analysis (13 papers) and Signaling Pathways in Disease (9 papers). Jerauld S. Skotnicki collaborates with scholars based in United States, Canada and Poland. Jerauld S. Skotnicki's co-authors include Jeremy I. Levin, Ker Yu, Philip Frost, Lourdes Toral‐Barza, Carolyn Discafani, J J Gibbons, Arie Zask, Loran M. Killar, Jefferson T. Eaton and Jerry Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

Jerauld S. Skotnicki

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerauld S. Skotnicki United States 22 934 530 466 385 185 51 1.7k
J. Scott Sawyer United States 25 1.2k 1.3× 911 1.7× 567 1.2× 203 0.5× 158 0.9× 50 2.4k
Elisa Nuti Italy 30 1.1k 1.2× 537 1.0× 857 1.8× 665 1.7× 228 1.2× 92 2.2k
Rima Al‐awar Canada 29 1.3k 1.4× 550 1.0× 498 1.1× 261 0.7× 133 0.7× 65 2.2k
Wim F. A. Steelant United States 22 1.1k 1.1× 753 1.4× 344 0.7× 372 1.0× 193 1.0× 35 2.5k
John A. Double United Kingdom 25 1.7k 1.8× 376 0.7× 423 0.9× 358 0.9× 105 0.6× 75 2.5k
Philip D. Edwards United States 24 712 0.8× 504 1.0× 221 0.5× 172 0.4× 194 1.0× 32 1.6k
John S. McMurray United States 31 1.6k 1.8× 551 1.0× 1.1k 2.3× 197 0.5× 119 0.6× 79 2.8k
Stephen M. Condon United States 18 1.8k 1.9× 463 0.9× 391 0.8× 506 1.3× 69 0.4× 38 2.5k
Michelandrea De Cesare Italy 31 2.1k 2.2× 512 1.0× 1.0k 2.2× 345 0.9× 169 0.9× 94 3.0k
Kiyohiro Nishikawa Japan 21 767 0.8× 348 0.7× 397 0.9× 150 0.4× 210 1.1× 56 1.4k

Countries citing papers authored by Jerauld S. Skotnicki

Since Specialization
Citations

This map shows the geographic impact of Jerauld S. Skotnicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerauld S. Skotnicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerauld S. Skotnicki more than expected).

Fields of papers citing papers by Jerauld S. Skotnicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerauld S. Skotnicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerauld S. Skotnicki. The network helps show where Jerauld S. Skotnicki may publish in the future.

Co-authorship network of co-authors of Jerauld S. Skotnicki

This figure shows the co-authorship network connecting the top 25 collaborators of Jerauld S. Skotnicki. A scholar is included among the top collaborators of Jerauld S. Skotnicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerauld S. Skotnicki. Jerauld S. Skotnicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kendrew, Steven G., Hrvoje Petković, Sabine Gaisser, et al.. (2012). Recombinant strains for the enhanced production of bioengineered rapalogs. Metabolic Engineering. 15. 167–173. 11 indexed citations
2.
Crabtree, Judy S., Scott A. Jelinsky, Heather A. Harris, et al.. (2009). Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway. Cancer Research. 69(15). 6171–6178. 83 indexed citations
3.
Hopper, Darrin W., Matthew D. Vera, Jason Xiang, et al.. (2009). Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: A class of potent aggrecanase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(9). 2487–2491. 20 indexed citations
4.
Glasson, S.S., A.M. Bendele, Phaik‐Eng Sum, et al.. (2009). 089 SELECTIVE AGGRECANASE INHIBITION IS DISEASE MODIFYING AND PAIN ALLEVIATING IN A RAT MENISCAL TEAR MODEL OF OSTEOARTHRITIS. Osteoarthritis and Cartilage. 17. S56–S56. 4 indexed citations
5.
Zask, Arie, Joshua A. Kaplan, Xuemei Du, et al.. (2005). Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(6). 1641–1645. 23 indexed citations
6.
Li, Jianchang, Thomas S. Rush, Wěi Li, et al.. (2005). Synthesis and SAR of highly selective MMP-13 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(22). 4961–4966. 55 indexed citations
7.
Li, Zhong, Gerardo D. Francisco, William Hu, et al.. (2003). 2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis. Bioorganic & Medicinal Chemistry Letters. 13(15). 2591–2594. 32 indexed citations
8.
Yu, Ker, Lourdes Toral‐Barza, Carolyn Discafani, et al.. (2001). mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.. Endocrine Related Cancer. 8(3). 249–258. 354 indexed citations
9.
Levin, Jeremy I., Frances C. Nelson, John F. DiJoseph, et al.. (2001). The discovery of anthranilic acid-based mmp inhibitors. Part 3: incorporation of basic amines. Bioorganic & Medicinal Chemistry Letters. 11(22). 2975–2978. 30 indexed citations
10.
Levin, Jeremy I., Yansong Gu, Frances C. Nelson, et al.. (2001). Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases. Bioorganic & Medicinal Chemistry Letters. 11(2). 239–242. 16 indexed citations
11.
Skotnicki, Jerauld S., Arie Zask, Frances C. Nelson, J. Donald Albright, & Jeremy I. Levin. (1999). Design and Synthetic Considerations of Matrix Metalloproteinase Inhibitors. Annals of the New York Academy of Sciences. 878(1). 61–72. 45 indexed citations
12.
Harris, David C.H., Reza Mortezaei, Lihong Shi, et al.. (1998). Malonyl α-mercaptoketones and α-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(10). 1157–1162. 19 indexed citations
13.
Zask, Arie, Jeremy I. Levin, Loran M. Killar, & Jerauld S. Skotnicki. (1996). Inhibition of Matrix Metalloproteinases: Structure Based Design. Current Pharmaceutical Design. 2(6). 624–661. 63 indexed citations
14.
Caccese, Robert, et al.. (1991). Inhibition of interleukin-1 (IL-1) induced neutral proteases from rabbit articular chondrocytes by WY-46,135 and WY-48,989. Inflammation Research. 34(1-2). 223–225. 14 indexed citations
15.
Taylor, Edward C., et al.. (1985). Synthesis of Ethyl 7,10-Ehtano-4-amino-4-deoxypteroate. Heterocycles. 23(7). 1703–1703. 2 indexed citations
16.
McDaniel, Keith F., et al.. (1984). ChemInform Abstract: SYNTHESIS OF 1‐(P‐CARBOMETHOXYPHENYL)‐3‐PYRROLIDINONE BY A DIELS‐ALDER ROUTE. Chemischer Informationsdienst. 15(49). 8 indexed citations
17.
Taylor, Edward C. & Jerauld S. Skotnicki. (1981). A Convenient Synthesis of 1-Aryl-4-piperidones. Synthesis. 1981(8). 606–608. 11 indexed citations
18.
Taylor, Edward C., Cynthia A. Maryanoff, & Jerauld S. Skotnicki. (1980). Heterocyclization with cyano and sulfonyl epoxides. Preparation of quinoxalines and tetrahydroquinoxalines. The Journal of Organic Chemistry. 45(12). 2512–2515. 21 indexed citations
19.
Skotnicki, Jerauld S., Robert E. Schaub, Martin J. Weiss, & F. Dessy. (1977). Prostaglandins and congeners. 14. Synthesis and bronchodilator activity of dl-16,16-trimethyleneprostaglandins. Journal of Medicinal Chemistry. 20(8). 1042–1047. 4 indexed citations
20.
Gribble, Gordon W., et al.. (1974). Reactions of sodium borohydride in acidic media. I. Reduction of indoles and alkylation of aromatic amines with carboxylic acids. Journal of the American Chemical Society. 96(25). 7812–7814. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Scott Sawyer Breakdown of academic impact, for papers by Elisa Nuti Breakdown of academic impact, for papers by Rima Al‐awar Breakdown of academic impact, for papers by Wim F. A. Steelant Breakdown of academic impact, for papers by John A. Double Breakdown of academic impact, for papers by Philip D. Edwards Breakdown of academic impact, for papers by John S. McMurray Breakdown of academic impact, for papers by Stephen M. Condon Breakdown of academic impact, for papers by Michelandrea De Cesare Breakdown of academic impact, for papers by Kiyohiro Nishikawa
Rankless by CCL
2026